National Institute of Allergy & Infectious Diseases (NIAID)

302 articles with National Institute of Allergy & Infectious Diseases (NIAID)

• New Flu Strain Picked For Flu Vaccine Mix

  2/17/2005

• Meridian Bioscience, Inc. (VIVO) Targets Biodefense Market By Providing Contract Services For BEI Resources

  2/9/2005

• Substance Protects Resilient Staph Bacteria

  2/4/2005

• Extra Copies Of Gene Protect Against AIDS

  1/7/2005

• First U.S. SARS Vaccine Trial Opens At National Institutes of Health (NIH)

  12/14/2004

• Postal Center Gets Anthrax Detection

  12/10/2004

• Scientists Discover Potential New Way To Control Drug-Resistant Bacteria

  9/27/2004

• Coley Pharmaceutical Group Announces $16.9 Million Research Contract From NIH For Development Of New Vaccine Adjuvants For Biodefense

  9/21/2004

• Rhode Island Biotechnology Company Wins NIH BioDefense Award; EpiVax Wins SBIR Phase I Grant Totaling $859,773 To Develop Tularemia Vaccine

  9/13/2004

• B Cells Gone Bad: Researchers Uncover How HIV Causes Abnormalities In Antibody-Producing Cells

  9/9/2004

• Caprion Wins US $13.1M Biodefense Research Contract

  8/10/2004

• Researchers Identify Better Hepatitis C Treatment For People With HIV

  7/30/2004

• New Method Enables Researchers To Make Human SARS Antibodies Quickly

  7/12/2004

• 3-D Structure Of Anthrax Toxin Complex Solved

  7/6/2004

• Mouse Study Could Aid Vaccine Designers

  6/1/2004

• HIV Patients Get Long-Term Boost With Short, Intermittent Drug Regimen

  4/30/2004

• Second NIAID SARS Vaccine Candidate Helps Mice Fend Off SARS

  4/21/2004

• Deadly Human Parasite Sequenced

  4/7/2004

• New Approaches Speed Ebola Vaccine Development

  3/24/2004

• Mouse Antibodies Thwart SARS Virus

  3/15/2004